title: Research on Parkinson disease.
authors.forename: John T
authors.initials: JT
authors.lastname: Slevin
authors.forename: Greg A
authors.initials: GA
authors.lastname: Gerhardt
authors.forename: Charles D
authors.initials: CD
authors.lastname: Smith
authors.forename: Don M
authors.initials: DM
authors.lastname: Gash
authors.forename: Richard
authors.initials: R
authors.lastname: Kryscio
authors.forename: Byron
authors.initials: B
authors.lastname: Young
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage*; D002408:Catheters, Indwelling; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D007260:Infusion Pumps; D009043:Motor Activity / Q000187:drug effects*; D009048:Motor Skills / Q000187:drug effects; D009414:Nerve Growth Factors / Q000008:administration & dosage*; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D011699:Putamen / Q000187:drug effects*; D011930:Reaction Time / Q000187:drug effects
chemical_list: D000978:Antiparkinson Agents; C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors